JOHNSON & JOHNSON : - New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA (ustekinumab) in Older Patients Across Approved Indications

Press/Media

Period5 Oct 2021

Media coverage

2

Media coverage